Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis.
Saved in:
| Title: | Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis. |
|---|---|
| Authors: | Burke, Chloe (AUTHOR), Freeman, Tom P. (AUTHOR), Sallis, Hannah (AUTHOR), Wootton, Robyn E. (AUTHOR), Burnley, Annabel (AUTHOR), Lange, Jonas (AUTHOR), Lees, Rachel (AUTHOR), Sawyer, Katherine (AUTHOR), Taylor, Gemma M. J. (AUTHOR) |
| Source: | Psychological Medicine. Nov2024, Vol. 54 Issue 15, p1-15. 15p. |
| Subjects: | Mental illness risk factors, Risk assessment, Medical information storage & retrieval systems, Research funding, Smoking, CINAHL database, Affective disorders, Meta-analysis, Descriptive statistics, Systematic reviews, MEDLINE, Psychoses, Anxiety disorders, Cannabis (Genus), Quality assurance, Psychology information storage & retrieval systems, Disease incidence |
| Geographic Terms: | United Kingdom |
| Abstract: | Background Observational studies consistently report associations between tobacco use, cannabis use and mental illness. However, the extent to which this association reflects an increased risk of new-onset mental illness is unclear and may be biased by unmeasured confounding. Methods A systematic review and meta-analysis (CRD42021243903). Electronic databases were searched until November 2022. Longitudinal studies in general population samples assessing tobacco and/or cannabis use and reporting the association (e.g. risk ratio [RR]) with incident anxiety, mood, or psychotic disorders were included. Estimates were combined using random-effects meta-analyses. Bias was explored using a modified Newcastle–Ottawa Scale, confounder matrix, E -values, and Doi plots. Results Seventy-five studies were included. Tobacco use was associated with mood disorders (K = 43; RR: 1.39, 95% confidence interval [CI] 1.30–1.47), but not anxiety disorders (K = 7; RR: 1.21, 95% CI 0.87–1.68) and evidence for psychotic disorders was influenced by treatment of outliers (K = 4, RR: 3.45, 95% CI 2.63–4.53; K = 5, RR: 2.06, 95% CI 0.98–4.29). Cannabis use was associated with psychotic disorders (K = 4; RR: 3.19, 95% CI 2.07–4.90), but not mood (K = 7; RR: 1.31, 95% CI 0.92–1.86) or anxiety disorders (K = 7; RR: 1.10, 95% CI 0.99–1.22). Confounder matrices and E -values suggested potential overestimation of effects. Only 27% of studies were rated as high quality. Conclusions Both substances were associated with psychotic disorders and tobacco use was associated with mood disorders. There was no clear evidence of an association between cannabis use and mood or anxiety disorders. Limited high-quality studies underscore the need for future research using robust causal inference approaches (e.g. evidence triangulation). [ABSTRACT FROM AUTHOR] |
| Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 182283792 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Burke%2C+Chloe%22">Burke, Chloe</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Freeman%2C+Tom+P%2E%22">Freeman, Tom P.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sallis%2C+Hannah%22">Sallis, Hannah</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wootton%2C+Robyn+E%2E%22">Wootton, Robyn E.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burnley%2C+Annabel%22">Burnley, Annabel</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lange%2C+Jonas%22">Lange, Jonas</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lees%2C+Rachel%22">Lees, Rachel</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sawyer%2C+Katherine%22">Sawyer, Katherine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Taylor%2C+Gemma+M%2E+J%2E%22">Taylor, Gemma M. J.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Psychological+Medicine%22">Psychological Medicine</searchLink>. Nov2024, Vol. 54 Issue 15, p1-15. 15p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Mental+illness+risk+factors%22">Mental illness risk factors</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+assessment%22">Risk assessment</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+information+storage+%26+retrieval+systems%22">Medical information storage & retrieval systems</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Smoking%22">Smoking</searchLink><br /><searchLink fieldCode="DE" term="%22CINAHL+database%22">CINAHL database</searchLink><br /><searchLink fieldCode="DE" term="%22Affective+disorders%22">Affective disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Meta-analysis%22">Meta-analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Systematic+reviews%22">Systematic reviews</searchLink><br /><searchLink fieldCode="DE" term="%22MEDLINE%22">MEDLINE</searchLink><br /><searchLink fieldCode="DE" term="%22Psychoses%22">Psychoses</searchLink><br /><searchLink fieldCode="DE" term="%22Anxiety+disorders%22">Anxiety disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabis+%28Genus%29%22">Cannabis (Genus)</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+assurance%22">Quality assurance</searchLink><br /><searchLink fieldCode="DE" term="%22Psychology+information+storage+%26+retrieval+systems%22">Psychology information storage & retrieval systems</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+incidence%22">Disease incidence</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+Kingdom%22">United Kingdom</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background Observational studies consistently report associations between tobacco use, cannabis use and mental illness. However, the extent to which this association reflects an increased risk of new-onset mental illness is unclear and may be biased by unmeasured confounding. Methods A systematic review and meta-analysis (CRD42021243903). Electronic databases were searched until November 2022. Longitudinal studies in general population samples assessing tobacco and/or cannabis use and reporting the association (e.g. risk ratio [RR]) with incident anxiety, mood, or psychotic disorders were included. Estimates were combined using random-effects meta-analyses. Bias was explored using a modified Newcastle–Ottawa Scale, confounder matrix, E -values, and Doi plots. Results Seventy-five studies were included. Tobacco use was associated with mood disorders (K = 43; RR: 1.39, 95% confidence interval [CI] 1.30–1.47), but not anxiety disorders (K = 7; RR: 1.21, 95% CI 0.87–1.68) and evidence for psychotic disorders was influenced by treatment of outliers (K = 4, RR: 3.45, 95% CI 2.63–4.53; K = 5, RR: 2.06, 95% CI 0.98–4.29). Cannabis use was associated with psychotic disorders (K = 4; RR: 3.19, 95% CI 2.07–4.90), but not mood (K = 7; RR: 1.31, 95% CI 0.92–1.86) or anxiety disorders (K = 7; RR: 1.10, 95% CI 0.99–1.22). Confounder matrices and E -values suggested potential overestimation of effects. Only 27% of studies were rated as high quality. Conclusions Both substances were associated with psychotic disorders and tobacco use was associated with mood disorders. There was no clear evidence of an association between cannabis use and mood or anxiety disorders. Limited high-quality studies underscore the need for future research using robust causal inference approaches (e.g. evidence triangulation). [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=182283792 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1017/S0033291724002587 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 1 Subjects: – SubjectFull: Mental illness risk factors Type: general – SubjectFull: Risk assessment Type: general – SubjectFull: Medical information storage & retrieval systems Type: general – SubjectFull: Research funding Type: general – SubjectFull: Smoking Type: general – SubjectFull: CINAHL database Type: general – SubjectFull: Affective disorders Type: general – SubjectFull: Meta-analysis Type: general – SubjectFull: Descriptive statistics Type: general – SubjectFull: Systematic reviews Type: general – SubjectFull: MEDLINE Type: general – SubjectFull: Psychoses Type: general – SubjectFull: Anxiety disorders Type: general – SubjectFull: Cannabis (Genus) Type: general – SubjectFull: Quality assurance Type: general – SubjectFull: Psychology information storage & retrieval systems Type: general – SubjectFull: Disease incidence Type: general – SubjectFull: United Kingdom Type: general Titles: – TitleFull: Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burke, Chloe – PersonEntity: Name: NameFull: Freeman, Tom P. – PersonEntity: Name: NameFull: Sallis, Hannah – PersonEntity: Name: NameFull: Wootton, Robyn E. – PersonEntity: Name: NameFull: Burnley, Annabel – PersonEntity: Name: NameFull: Lange, Jonas – PersonEntity: Name: NameFull: Lees, Rachel – PersonEntity: Name: NameFull: Sawyer, Katherine – PersonEntity: Name: NameFull: Taylor, Gemma M. J. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00332917 Numbering: – Type: volume Value: 54 – Type: issue Value: 15 Titles: – TitleFull: Psychological Medicine Type: main |
| ResultId | 1 |